23:39

Expert Perspectives: JAK Inhibitors for Polycythemia Vera

HMP Education

19:36

Evolution of the Assessment of Clinical Benefit in Polycythemia Vera

HMP Education

15:55

Debate: Should JAK Inhibitors use be Limited to Hydroxyurea-resistant/intolerant PV Patients? - Yes

HMP Education

9:19

Debate: Should JAK Inhibitors use be Limited to Hydroxyurea-resistant/intolerant PV Patients? - No

HMP Education